Content area

Abstract

Abstract

Purpose

Floppy eyelid syndrome (FES) is a clinical entity characterized by palpebral hyperlaxity and chronic conjunctivitis. Patients’ eyelids evert (“flip inside out”), leading to eye irritation, dryness, grittiness, and tearing. More severe cases can lead to significant ocular complications, such as keratoconus and impaired eyesight. Research has revealed an association between FES and obstructive sleep apnea syndrome (OSAS). OSAS is also one of the most common comorbidities among patients with obesity and an indication for bariatric surgery. This is one of the first studies to explore FES in a group of patients who have undergone bariatric surgery.

Materials and Methods

This was a retrospective study. A total of 88 patients completed a survey by mail or telephone. Additional data on demographics and baseline preoperative clinical information was extracted from the online medical records and the MBSAQIP database.

Results

Thirty-nine patients (44%) recalled having chronic ocular symptoms before their bariatric surgery, among whom six reported palpebral laxity and/or an established diagnosis of FES. The majority of them (67%) rated their symptoms postoperatively as “somewhat” or “significantly improved.” The patients that reported improvement in their ocular symptoms also experienced an improvement in their OSAS severity.

Conclusion

Bariatric surgery might affect the clinical course of FES and the severity of symptoms. Treating OSAS, the underlying mechanism of FES, is a possible mechanism of how bariatric surgery can help patients. It is also critical for bariatric surgeons to consider FES when patients with obesity, particularly those with OSAS, present with chronic eye symptoms.

Details

Title
Floppy Eyelid Syndrome: an Overlooked Comorbidity Among Bariatric Patients
Author
Zoumpou, Theofano 1   VIAFID ORCID Logo  ; Samuel, Sandy 2 ; Torun, Nurhan 3 ; Yadav, Prashant 4 ; Jones, Daniel B. 1 

 Rutgers, The State University of New Jersey, Department of Surgery, New Jersey Medical School, Newark, USA (GRID:grid.430387.b) (ISNI:0000 0004 1936 8796) 
 Harvard Medical School, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X) 
 Harvard Medical School, Beth Israel Deaconess Medical Center, Department of Ophthalmology, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X) 
 Massachusetts Eye and Ear Infirmary, Boston, USA (GRID:grid.39479.30) (ISNI:0000 0000 8800 3003) 
Pages
523-529
Publication year
2023
Publication date
Feb 2023
Publisher
Springer Nature B.V.
ISSN
0960-8923
e-ISSN
1708-0428
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2771189693
Copyright
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.